Back to search

Article

HBO1 Suppresses Anti-Tumor Immunity of CD8⁺ T Cells in Thyroid Cancer by Recruiting BRD4 to Regulate VTCN1 Expression

2026-03-25

Abstract excerpt

<title>Abstract</title> <p> Thyroid cancer is the most common endocrine malignancy. Although surgery remains the primary treatment, advanced disease frequently recurs or metastasizes, and subsequent therapies yield suboptimal outcomes. Immunotherapy holds promise, yet the underlying immune-evasion mechanisms remain incompletely understood. HBO1, a multifunctional acyltransferase, plays a significant role in tumo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
de34b7a5-b291-5c0c-917e-599ae36f6aba
DOI
10.21203/rs.3.rs-9138728/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
HBO1 Suppresses Anti-Tumor Immunity of CD8⁺ T Cells in Thyroid Cancer by Recruiting BRD4 to Regulate VTCN1 ExpressionDOI 10.21203/rs.3.rs-9138728/v1
Select a neighboring publication to make it the new centre.